[P‐192]: Clinical Progestins and Their Efficacy to Promote Neuron Survival and Neurogenesis
Jinxia Deng,Jon Nilsen,Roberta Diaz Brinton
DOI: https://doi.org/10.1016/j.jalz.2005.06.251
2005-01-01
Abstract:We previously demonstrated that progesterone functions as a neuroprotective agent whereas medroxyprogesterone acetate (MPA) does not (Nilsen and Brinton, Endocrinology, 2001; Nilsen and Brinton, PNAS, 2003). Moreover, MPA antagonizes the neuroprotective and neurotrophic mechanisms of 17β-estradiol (E2). Blockade of estrogen-inducible mechanisms of neuroprotection would obstruct estrogen prevention of degenerative insults that culminate in Alzheimer's disease (Brinton and Nilsen, JAMA, 2003). To develop effective hormone therapies that prevent Alzheimer's, we have analyzed clinically relevant progestins for neuroprotective and neurogenic efficacy. Further we seek to determine the chemical structural features that predict progestin efficacy in brain. Primary hippocampal neurons were pretreated with the selected progestins prior to exposure to excitotoxic glutamate or Aβ1-42 and assessed for neuronal survival by calcein-AM/ethidium homodimer dual labeling. We used computational modeling to predict docking of the tested progestins into progesterone receptor and empirically determined the receptor binding affinity of the compounds using a fluorescence polarization competition assay. Natural progesterone and the progestins, norethindrone acetate and norgestimate were protective against excitotoxic glutamate and Aβ1-42 whereas norethindrone, ethinodiol diacetate, norethynodrel, levonorgestrel and medroxyprogesterone were not. Analysis of progestin-induced neural stem cell proliferation demonstrates comparable complexity of chemical structure dependency. Further, we show that binding affinity does not predict neuroprotective efficacy or the direction of effect and thus cannot be used as an indicator of neurological benefit. Importantly, in vitro analysis of neuroprotective efficacy could serve as a predictive index of clinical efficacy for progestins to protect against degenerative insults that lead to Alzheimer's disease.
What problem does this paper attempt to address?